Unlock AI-driven, actionable R&D insights for your next breakthrough.

Acetyl Hexapeptide-8 Functional Groups: Molecular Architecture, Chemical Reactivity, And Applications In Anti-Aging Cosmetics

NOV 17, 202655 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Acetyl Hexapeptide-8 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), a synthetic hexapeptide widely recognized for its anti-wrinkle efficacy, owes its biological activity and formulation versatility to a precisely orchestrated array of functional groups. Understanding the molecular architecture—including the N-terminal acetyl moiety, side-chain functionalities (carboxyl, thioether, amide, guanidinium), and C-terminal amide—is essential for R&D professionals seeking to optimize synthesis routes, enhance transdermal delivery, and engineer next-generation cosmetic actives. This article provides an in-depth analysis of each functional group's chemical properties, reactivity, and role in peptide stability, bioavailability, and mechanism of action, supported by recent patent literature and analytical methodologies.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Composition And Structural Characteristics Of Acetyl Hexapeptide-8

Acetyl Hexapeptide-8 (CAS 616204-22-9, molecular formula C₃₄H₆₀N₁₄O₁₂S, molecular weight 888.91 Da) is a linear hexapeptide comprising the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂ 1. The peptide's architecture integrates multiple functional groups that collectively govern its physicochemical behavior, synthetic accessibility, and biological performance. The N-terminus is capped with an acetyl group (–COCH₃), which eliminates the free amino group and imparts lipophilicity while preventing enzymatic degradation by aminopeptidases 3. The C-terminus is amidated (–CONH₂), a modification that enhances metabolic stability by blocking carboxypeptidase cleavage and improves receptor affinity 4. Between these termini, the peptide backbone contains six amino acid residues, each contributing distinct side-chain functionalities:

  • Glutamic acid (Glu, positions 1 and 2): Two γ-carboxyl groups (–COOH) that are ionizable (pKa ~4.2), conferring negative charge at physiological pH and enabling salt bridge formation with cationic residues or metal ions 6.
  • Methionine (Met, position 3): A thioether side chain (–CH₂–CH₂–S–CH₃) susceptible to oxidation, forming methionine sulfoxide or sulfone under oxidative stress, which can compromise peptide activity 5,9.
  • Glutamine (Gln, position 4): A primary amide side chain (–CONH₂) that participates in hydrogen bonding and is prone to deamidation (conversion to glutamic acid) under acidic or basic conditions, particularly at elevated temperatures 14.
  • Arginine (Arg, positions 5 and 6): Two guanidinium groups (–NH–C(=NH)–NH₂⁺) that remain protonated across a wide pH range (pKa ~12.5), providing strong positive charge and enabling electrostatic interactions with anionic phospholipids in cell membranes or negatively charged SNARE protein domains 2,7.

The peptide's overall charge at pH 5.5–6.5 (typical cosmetic formulation range) is approximately +1 to +2, balancing the two anionic Glu residues against the two cationic Arg residues and the neutral acetyl/amide termini 9. This amphipathic character—hydrophilic charged residues flanking a central hydrophobic Met—facilitates interaction with both aqueous and lipid environments, a prerequisite for transdermal penetration 7,12.

Functional Groups: Chemical Properties, Reactivity, And Stability Considerations

N-Terminal Acetyl Group: Lipophilicity And Enzymatic Protection

The acetyl moiety (CH₃CO–) at the N-terminus is introduced via acetylation of the terminal amino group, typically using acetic anhydride or acetyl chloride in organic solvents such as pyridine or dichloromethane during solid-phase peptide synthesis (SPPS) 3,4,6. This modification serves three critical functions:

  1. Enhanced lipophilicity: The acetyl group increases the peptide's partition coefficient (log P), improving solubility in non-polar solvents and facilitating incorporation into oil-based formulations or liposomal carriers 12.
  2. Enzymatic stability: Blocking the free α-amino group prevents cleavage by aminopeptidases, extending the peptide's half-life in biological matrices 3.
  3. Reduced immunogenicity: Acetylation masks a potential site for immune recognition, lowering the risk of allergic reactions in topical applications 8.

Analytical characterization of the acetyl group is routinely performed by high-performance liquid chromatography–mass spectrometry (HPLC-MS), where the intact peptide exhibits a molecular ion [M+H]⁺ at m/z 889.4, and fragmentation patterns confirm the presence of the N-terminal Ac-Glu residue 5. Infrared (IR) spectroscopy reveals a characteristic carbonyl stretch at ~1650 cm⁻¹, distinct from the amide I band of the peptide backbone 6.

Glutamic Acid Carboxyl Groups: Ionization, Salt Formation, And Complexation

The two γ-carboxyl groups of Glu¹ and Glu² are weak acids (pKa ~4.2) that exist predominantly as carboxylate anions (–COO⁻) at pH >5 9. These groups contribute to:

  • Solubility in aqueous media: The anionic character enhances water solubility, with reported solubility of acetyl hexapeptide-8 in deionized water exceeding 50 mg/mL at 25°C 9.
  • Salt bridge formation: Carboxylates can form intramolecular or intermolecular ionic interactions with the guanidinium groups of Arg⁵ and Arg⁶, stabilizing secondary structure or promoting self-assembly into oligomers 2.
  • Metal ion coordination: Carboxyl groups chelate divalent cations (Ca²⁺, Mg²⁺, Zn²⁺), which may modulate peptide conformation or facilitate delivery across the stratum corneum 7.

However, the carboxyl groups also pose formulation challenges. In acidic environments (pH <4), protonation reduces solubility and may trigger aggregation or precipitation 9. Patent CN113398236B 9 addresses this by incorporating fruit acid derivatives (glycolic acid, citric acid, lactic acid, or their sodium salts) at 1.0–5.0 wt% to buffer the formulation to pH 4.5–6.5, maintaining carboxylate ionization and preventing peptide crystallization. Stability studies demonstrated that formulations with citric acid retained >85% peptide content after 6 months at 45°C, compared to <70% in unbuffered controls 9.

Methionine Thioether: Oxidative Vulnerability And Stabilization Strategies

The thioether sulfur (–S–) in Met³ is highly susceptible to oxidation by reactive oxygen species (ROS), peroxides, or atmospheric oxygen, yielding methionine sulfoxide (MetO) or, under harsher conditions, methionine sulfone (MetO₂) 5,14. Oxidation at Met³ disrupts the peptide's three-dimensional structure and abolishes its ability to inhibit SNARE complex formation, thereby eliminating anti-wrinkle efficacy 5. Analytical methods to quantify Met oxidation include:

  • Reversed-phase HPLC (RP-HPLC): Oxidized peptides elute earlier than the native form due to increased polarity; patent CN116925152A 14 specifies that methionine oxidation-related peaks must not exceed 0.8% of total peak area for batch release 14.
  • Mass spectrometry: MetO adds +16 Da (m/z 905.4 for [M+H]⁺), while MetO₂ adds +32 Da (m/z 921.4) 5.

To mitigate oxidation, several strategies have been developed:

  1. Antioxidant co-formulation: Patent CN116925152A 14 employs a low-temperature polyol-polysaccharide protective system comprising 10–30 wt% glycerol or propylene glycol and 0.5–2.0 wt% sodium hyaluronate or xanthan gum, which scavenge ROS and form a hydration shell around Met³, reducing oxidation rates by >60% at 45°C over 6 months 14.
  2. Inert atmosphere packaging: Nitrogen or argon flushing during manufacturing and storage minimizes oxygen exposure 9.
  3. pH control: Maintaining pH 5.0–6.0 slows oxidation kinetics; patent CN113398236B 9 reports that formulations at pH 5.5 exhibited <2% MetO formation after 6 months, versus >8% at pH 7.5 9.
  4. Crystalline polymorphs: Patent CN118724896A 13 discloses three novel crystal forms (C, D, E) of acetyl hexapeptide-8 that exhibit superior oxidative stability compared to lyophilized powder or polymorph B. Oil-soluble formulations prepared from polymorph C retained 80–85% peptide content at 45°C, versus 65–70% for lyophilized powder 13.

Glutamine Amide: Deamidation Pathways And Formulation pH

The primary amide (–CONH₂) of Gln⁴ undergoes deamidation via nucleophilic attack by the backbone nitrogen of the succeeding residue (Arg⁵), forming a cyclic imide intermediate that hydrolyzes to a mixture of glutamic acid and iso-glutamic acid 14. Deamidation is accelerated by:

  • Elevated temperature: Rates double for every 10°C increase above 25°C 14.
  • Extreme pH: Both acidic (pH <3) and basic (pH >8) conditions catalyze deamidation, with maximum stability at pH 4.5–6.0 9,14.
  • Ionic strength: High salt concentrations (>0.5 M NaCl) destabilize the peptide backbone, promoting deamidation 14.

Patent CN116925152A 14 specifies that related peptide impurities (including deamidated species) must not exceed 2.0% for batch release, and recommends storage at ≤25°C and pH 5.0–6.0 to minimize deamidation 14. Analytical detection employs RP-HPLC with UV detection at 214 nm, where deamidated peptides elute slightly earlier due to the introduction of a carboxyl group 5.

Arginine Guanidinium Groups: Electrostatic Interactions And Membrane Penetration

The two guanidinium moieties (–C(=NH)–NH₂⁺) of Arg⁵ and Arg⁶ remain fully protonated across pH 2–12, conferring a persistent +2 charge that drives multiple biological and formulation phenomena 2,7:

  • SNARE protein binding: The guanidinium groups form bidentate hydrogen bonds and salt bridges with negatively charged residues (Asp, Glu) in the SNAP-25 protein, competitively inhibiting SNARE complex assembly and reducing acetylcholine release at neuromuscular junctions, thereby attenuating facial muscle contraction 2.
  • Cell-penetrating peptide (CPP) character: Arginine-rich sequences facilitate transdermal delivery by interacting with anionic phospholipid headgroups (phosphatidylserine, phosphatidylinositol) in the stratum corneum, inducing transient membrane perturbation and endocytosis 7,11.
  • Aggregation propensity: At high concentrations (>5 wt%), electrostatic repulsion between guanidinium groups can be overcome by hydrophobic interactions involving Met³ and the acetyl group, leading to oligomerization or gel formation 9. Patent CN113398236B 9 mitigates this by limiting peptide concentration to 3.0–15.0 wt% and adding polysaccharide polymers (sodium hyaluronate, xanthan gum) at 0.1–2.0 wt% to sterically stabilize the peptide in solution 9.

C-Terminal Amide: Metabolic Stability And Receptor Affinity

The C-terminal amide (–CONH₂) is introduced by cleaving the peptide from a Rink Amide resin during SPPS, or by enzymatic amidation using peptidylglycine α-amidating monooxygenase (PAM) in biosynthetic routes 4,16. This modification:

  • Blocks carboxypeptidase cleavage: Prevents sequential removal of C-terminal residues, extending peptide half-life in skin tissue from ~30 min (free carboxyl) to >4 h (amide) 4.
  • Enhances receptor binding: The neutral amide terminus better mimics the natural SNAP-25 substrate, improving affinity for SNARE complex binding sites 2.
  • Reduces acidity: Eliminates a free carboxyl group, raising the peptide's isoelectric point (pI) from ~3.5 to ~8.5, which improves compatibility with cationic surfactants and polymers in formulations 9.

Analytical confirmation of C-terminal amidation is achieved by tandem mass spectrometry (MS/MS), where fragmentation of the [M+H]⁺ ion yields a characteristic y₁ fragment at m/z 175.1 (Arg-NH₂) 5.

Synthesis Strategies: Solid-Phase Versus Liquid-Phase Approaches And Functional Group Protection

Solid-Phase Peptide Synthesis (SPPS): Fmoc Strategy And Side-Chain Protection

The majority of acetyl hexapeptide-8 production employs Fmoc-based SPPS on Rink Amide resin, which directly yields the C-terminal amide upon cleavage 4,6. The synthesis proceeds as follows:

  1. Resin loading: Rink Amide-AM resin (loading 0.5–0.8 mmol/g) is swelled in DMF and deprotected with 20% piperidine/DMF (2 × 10 min) to expose the free amino group 4.
  2. Amino acid coupling: Fmoc-protected amino acids are coupled sequentially in reverse order (Arg⁶ → Arg⁵ → Gln⁴ → Met³ → Glu² → Glu¹) using coupling reagents such as modified N-hydroxyphthalimide (p-dimethylquinone-modified HOBt) and DIC, achieving >99% coupling efficiency per cycle 6. Side-chain protecting groups include:
    • Glu: tert-butyl ester (OtBu) to mask the γ-carboxyl 3,4.
    • Met: typically unprotected, though some protocols use methionine sulfoxide to prevent oxidation during synthesis, followed by reduction with dithiothreitol (DTT) 5.
    • Gln: trityl (Trt) to protect the amide side chain from dehydration 3.
    • Arg: 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl (Pbf) to protect the guanidinium group 3,4.
  3. N-terminal acetylation: After coupling Glu¹, the resin is treated with acetic anhydride (10 equiv.) and DIEA (20 equiv.) in DMF for 30 min to acetylate the terminal amino group 3,6.
  4. Cleavage and deprotection: The peptide is cleaved from the resin and all side-chain protecting groups are removed simultaneously using a
OrgApplication ScenariosProduct/ProjectTechnical Outcomes
浙江湃肽生物有限公司南京分公司Quality control and analytical testing of acetyl hexapeptide-8 raw materials in cosmetic manufacturing, particularly for monitoring carboxyl, thioether, and guanidinium functional groups.Acetyl Hexapeptide-8 Detection KitPre-column derivatization with amino-derivative reagents (dimethyl-imidazo-pyridinyl-methanol or dimethoxymethyl-furano-pyridinyl-methanol) combined with HPLC analysis achieves excellent detection sensitivity, accuracy and repeatability for acetyl hexapeptide-8 functional group characterization.
杭州信海医药科技有限公司Large-scale solid-phase peptide synthesis for cosmetic active ingredient production, ensuring functional group integrity during acetylation and amidation steps.Acetyl Hexapeptide-8 SPPS Synthesis PlatformUtilizes modified N-hydroxyphthalimide (p-dimethylquinone-modified HOBt) as condensing agent with DIC, achieving >99% coupling efficiency per cycle and high-purity acetyl hexapeptide-8 with intact N-terminal acetyl and C-terminal amide functional groups.
陕西慧康生物科技有限责任公司Anti-wrinkle facial serums and eye creams requiring high peptide concentration with stabilized functional groups (carboxyl, thioether, guanidinium) for extended shelf life.High-Content Acetyl Hexapeptide-8 Transparent Cosmetic SerumIncorporates 3.0-15.0 wt% acetyl hexapeptide-8 with fruit acid derivatives (1.0-5.0 wt%) and polysaccharide polymers (0.1-2.0 wt%) at pH 4.5-6.5, maintaining carboxyl group ionization and preventing methionine oxidation, retaining >85% peptide content after 6 months at 45°C.
SHENZHEN READLINE BIOTECHNOLOGY CO. LTD.Oil-based anti-aging cosmetics and lipophilic delivery systems requiring enhanced protection of methionine thioether and other reactive functional groups against oxidation.Acetyl Hexapeptide-8 Crystal Polymorphs (C, D, E)Novel crystal forms C, D, and E exhibit superior oxidative stability of methionine thioether group compared to lyophilized powder, with oil-soluble formulations retaining 80-85% peptide content at 45°C versus 65-70% for conventional forms.
汉肽生物医药集团有限公司Industrial-scale production of acetyl hexapeptide-8 for cosmetic applications, with optimized protection and deprotection of multiple functional groups in sequential coupling reactions.Liquid-Phase Acetyl Hexapeptide-8 Synthesis SystemEmploys liquid-phase 2+2+2 strategy synthesizing three dipeptide monomers (Ac-Glu-Glu-OH, H-Met-Gln-OH, H-Arg-Arg-NH2) with protected functional groups (tBu for carboxyl, Trt for amide, Pbf for guanidinium), expanding synthesis scale while reducing organic solvent consumption.
Reference
  • Acetyl hexapeptide as well as preparation method and application thereof
    PatentPendingCN122011095A
    View detail
  • A complex acetyl hexapeptide-1 and its transdermal formulation and application
    PatentActiveCN114917139B
    View detail
  • A method for liquid-phase synthesis of acetyl hexapeptide-8
    PatentActiveCN113845586B
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png